Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

apamistamab

A murine IgG1 anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity. CD45 antigen, a receptor protein-tyrosine phosphatase essential for T cell development and lymphocyte activation, is expressed on virtually all leukocytes. Apamistamab has specificity for hematopoietic tissues and may be used in targeted immunotherapy.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-CD45 monoclonal antibody BC8
monoclonal antibody BC8
Code name:BC8
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search